Primary nonadherence to statin medications in a managed care organization

Journal of Managed Care Pharmacy

Volumn 19, Issue 5, 2013, Pages 367-373

  Cheetham, T Craig ^a   Niu, Fang ^a   Green, Kelley ^a   Scott, Ronald D ^a   Derose, Stephen F ^a   Vansomphone, Southida S ^a   Shin, Janet ^a   Tunceli, Kaan ^b   Reynolds, Kristi ^a  

^a KAISER PERMANENTE   (United States)

^b Global Health Outcomes Merck   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONSULTATION; DEMOGRAPHY; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE SYSTEM; HEALTH STATUS; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PREDICTION; PRESCRIPTION; SOCIOECONOMICS; TREATMENT REFUSAL;

EID: 84877768117     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2013.19.5.367     Document Type: Article

References (21)

1. Joyce GF. Understanding primary nonadherence. Am J Pharm Benefits. 2010;2(2):109-10.
2. Solomon MD, Majumdar SR. Primary nonadherence of medications: lifting the veil on prescription-taking behaviors. J Gen Intern Med. 2010;25(4):280-81.
3. Fischer MA, Stedman MR, Lii J, et al. Primary medication nonadherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25(4):284-90. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842539/pdf/11606_2010_Article_1253.pdf. Accessed March 23, 2013.
4. Liberman JN, Hutchins DS, Popiel RG, Patel MH, Jan SA, Berger JE. Determinants of primary nonadherence in asthma-controller and dyslipidemia pharmacotherapy. Am J Pharm Benefits. 2010;2(2):111-18.
5. Raebel MA, Ellis JL, Carroll NM, et al. Characteristics of patients with primary nonadherence to medications for hypertension, diabetes, and lipid disorders. J Gen Intern Med. 2012;27(1):57-64.
6. Gadkari AS, McHorney CA. Medication nonfulfillment rates and reasons: narrative systematic review. Curr Med Res Opin. 2010;26(3):683-705.
7. Karter AJ, Parker MM, Moffet HH, Ahmed AT, Schmittdiel JA, Selby JV. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res. 2009;44(5 Pt 1):1640-61. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754552/pdf/hesr0044-1640.pdf. Accessed March 23, 2013.
8. Koebnick C, Langer-Gould R, Gould M, et al. Sociodemographic characteristics of members of a large, integrated health care system: comparison with U.S. census bureau data. Perm J. 2012;16(3):27-41.
9. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-39.
10. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075-79.
11. Romano PS, Roos LL, Jollis JG. Further evidence concerning the use of a clinical comorbidity index with ICD-9-CM administrative data. J Clin Epidemiol. 1993;46:1085-90.
12. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons, Inc.; 2000.
13. Steiner JF. Can we identify clinical predictors of medication adherence... and should we? Med Care. 2010;48(3):193-95.
14. McHorney CA, Spain CV. Frequency of and reasons for medication nonfulfillment and nonpersistence among American adults with chronic disease in 2008. Health Expect. 2011;14(3):307-20.
15. Fung V, Sinclair F, Wang H, Dailey D, Hsu J, Shaber R. Patients' perspectives on nonadherence to statin therapy: a focus-group study. Perm J. 2010;14(1):4-10. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912713/pdf/prjl.14.1.004.pdf. Accessed March 23, 2013.
16. Derose SF, Green K, Marrett E, et al. Automated outreach to increase primary adherernce to cholesterol lowering medications. JAMA. 2013;173(1):38-43.
17. Simpson RJ, Mendys P. The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review. J Clin Lipidology. 2010;4:462-71.
18. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and health care cost. Med Care. 2005;43(6):521-30.
19. Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood). 2011;30(1):91-99.
20. Nasseh K, Grazee SF, Visaria J, Vlahiotis A, Tian Y. Cost of medication nonadherence associated with diabetes, hypertension, and dyslipidemia. Am J Pharm Benefits. 2012;4(2):e41-e47.
21. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.